Chembio Diagnostics Inc develops, manufacture market & licenses rapid point of care diagnostic tests that detect infectious diseases. Its products are rapid tests for the detection of HIV 1/2 antibodies, & for the detection of HIV & Syphilis antibodies.
Website: | www.chembio.com |
Email: | snorcott@chembio.com |
Main Phone: | +1 631 924-1135 |
Address: | 3661 Horseblock Road |
State: | NY |
City / Town: | Medford |
Country: | USA |
Postal Code: | 11763 |
Exchange: | NSC |
Employees: | 155 |
NAICS: | In-Vitro Diagnos |
Last Price 7.90 | Change $ 0. | Change % 0.00 | Tick N/A |
Bid 0. | Bid Size 0.00 | Ask 0. | Ask Size 0.00 |
Open 7.90 | High 7.95 | Low 7.85 | Prev Close 7.90 |
Last Trade | Volume 6,197 | 52 Wk Hi 9.20 | 52 Wk Low 5.70 |
Market Cap 111.9 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
Shares 14,162,702.00 | EPS (TTM) -0.52 | PE Ratio N/A | Exchange NCM |
|
|
Last 3 Mo | Last 12 Mo | |
---|---|---|
Number of Insider Trades | 11 | 23 |
Number of Buys | 6 | 8 |
Number of Sells | 5 | 15 |
Net Activity | 18047 | -19088 |
Last 10 Buys | Shares |
---|---|
Peter T. Kissinger | 1,000 |
Sharon Klugewicz | 1,000 |
Gary Meller | 1,000 |
Katherine L. Davis | 1,000 |
Katherine L. Davis | 1,000 |
Gary Meller | 1,000 |
Katherine L. Davis | 1,000 |
Katherine L. Davis | 1,000 |
Katherine L. Davis | 1,000 |
Gary Meller | 1,000 |
Last 10 Sell | Shares |
---|---|
Sharon Klugewicz | 1,000 |
Javan Esfandiari | 1,000 |
Javan Esfandiari | 1,000 |
Javan Esfandiari | 1,000 |
Richard J. Larkin | 1,000 |
Javan Esfandiari | 1,000 |
Javan Esfandiari | 1,000 |
Lawrence A. Siebert | 1,000 |
Lawrence A. Siebert | 1,000 |
Lawrence A. Siebert | 1,000 |
Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
---|---|---|---|---|
High Target Price Estimate | 10 | 10 | 10 | 10 |
Low Target Price Estimate | 7.75 | 7.75 | 7.75 | 7.5 |
Mean Target Price Estimate | 8.92 | 8.92 | 8.58 | 8.83 |
Standard Deviation | 1.13 | 1.13 | 1.23 | 1.26 |
Date of Most Recent Estimate | 08/11/16 | 08/11/16 | 07/25/16 | 08/15/16 |
Form Type | Form Description | Pages | Date |
---|---|---|---|
8-K | Report of unscheduled material events or corporate changes. | 3 | 2016-08-25 |
8-K | Report of unscheduled material events or corporate changes. | 3 | 2016-08-18 |
8-K | Report of unscheduled material events or corporate changes. | 8 | 2016-08-11 |
10-Q | Quarterly report with a continuing view of a company's financial position | 30 | 2016-08-11 |
8-K | Report of unscheduled material events or corporate changes. | 3 | 2016-08-04 |
8-K | Report of unscheduled material events or corporate changes. | 3 | 2016-08-03 |
8-K | Report of unscheduled material events or corporate changes. | 6 | 2016-07-29 |
424B5 | Prospectus filed under Rule 424(b)(5) | 70 | 2016-07-29 |
8-K | Report of unscheduled material events or corporate changes. | 3 | 2016-07-27 |
8-K | Report of unscheduled material events or corporate changes. | 5 | 2016-07-25 |
Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 |
Moderate Buy | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 |
Moderate Sell | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 |
Mean Rec. | 1 | 1 | 1 | 1 |